Evidence for histamine release in chronic inducible urticaria – A systematic review

dc.contributor.authorKulthanan K.
dc.contributor.authorChurch M.K.
dc.contributor.authorGrekowitz E.M.
dc.contributor.authorHawro T.
dc.contributor.authorKiefer L.A.
dc.contributor.authorMunprom K.
dc.contributor.authorNanchaipruek Y.
dc.contributor.authorRujitharanawong C.
dc.contributor.authorTerhorst-Molawi D.
dc.contributor.authorMaurer M.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:22:56Z
dc.date.available2023-06-18T17:22:56Z
dc.date.issued2022-07-28
dc.description.abstractBackground: Chronic inducible urticaria (CIndU) constitutes a group of nine different CIndUs in which pruritic wheals and/or angioedema occur after exposure to specific and definite triggers. Histamine released from activated and degranulating skin mast cells is held to play a key role in the pathogenesis of CIndU, but evidence to support this has, as of yet, not been reviewed systematically or in detail. We aim to characterize the role and relevance of histamine in CIndU. Methods: We systematically searched 3 electronic databases (PubMed, Scopus, and Embase) for studies that reported increased serum or skin histamine concentration (direct evidence) or in vitro or ex vivo histamine release (indirect evidence) following trigger exposure. Results: An initial total of 3,882 articles was narrowed down to 107 relevant studies of which 52 were in cold urticaria, 19 in cholinergic urticaria, 14 in heat urticaria, 10 in contact urticaria, 7 each in solar urticaria and vibratory angioedema, 4 each in symptomatic dermographism and aquagenic urticaria, and 3 in delayed pressure urticaria. The results of our review support that histamine has a key pathogenic role in the pathogenesis of all CIndUs, but it is not the sole mediator as evidenced by the often poor relationship between the level of histamine and severity of symptoms and the variable clinical efficacy of H1-antihistamines. Conclusions: Histamine released from skin mast cells is a key driver of the development of signs and symptoms and a promising therapeutic target in CIndU.
dc.identifier.citationFrontiers in Immunology Vol.13 (2022)
dc.identifier.doi10.3389/fimmu.2022.901851
dc.identifier.eissn16643224
dc.identifier.scopus2-s2.0-85135799868
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/84950
dc.rights.holderSCOPUS
dc.subjectImmunology and Microbiology
dc.titleEvidence for histamine release in chronic inducible urticaria – A systematic review
dc.typeReview
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85135799868&origin=inward
oaire.citation.titleFrontiers in Immunology
oaire.citation.volume13
oairecerif.author.affiliationFraunhofer Institute for Translational Medicine and Pharmacology ITMP
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationCharité – Universitätsmedizin Berlin
oairecerif.author.affiliationUniversitätsklinikum Schleswig-Holstein Campus Lübeck

Files

Collections